Economic Burden of Reported Lyme Disease in High-Incidence Areas, United States, 2014–2016
Sarah A. Hook

, Seonghye Jeon, Sara A. Niesobecki, AmberJean P. Hansen, James I. Meek, Jenna K.H. Bjork, Franny M. Dorr, Heather J. Rutz, Katherine A. Feldman, Jennifer L. White, P. Bryon Backenson, Manjunath B. Shankar, Martin I. Meltzer, and Alison F. Hinckley
Author affiliations: Centers for Disease Control and Prevention, Fort Collins, Colorado, USA (S.A. Hook, A.F. Hinckley); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S. Jeon, M.B. Shankar, M.I. Meltzer); Connecticut Emerging Infections Program, Yale School of Public Health, New Haven, Connecticut, USA (S.A. Niesobecki, A.P. Hansen, J.I. Meek); Minnesota Department of Health, St. Paul, Minnesota, USA (J.K.H. Bjork, F.M. Dorr); Maryland Department of Health, Baltimore, Maryland, USA (H.J. Rutz, K.A. Feldman); New York State Department of Health, Albany, New York, USA (J.L. White, P.B. Backenson)
Main Article
Table 4
Societal perspective of medical cost of Lyme disease per participant, by disease category, in high-incidence areas, United States, 2014–2016
Disease category
|
No. participants
|
Societal perspective, medical cost per participant,* 2016 US dollars
|
Median
|
Mean
|
SD
|
10th percentile
|
90th percentile
|
Range
|
All† |
613 |
478 |
1,333 |
5,690 |
164 |
1,932 |
50–121,869 |
Confirmed localized |
273 |
374 |
668 |
1,715 |
136 |
1,224 |
50–13,050 |
Confirmed disseminated |
154 |
696 |
2,537 |
20,220 |
259 |
4,366 |
147–121,869 |
Probable |
186 |
612 |
1,804 |
15,188 |
237 |
2,454 |
124–105,494 |
Main Article
Page created: April 03, 2022
Page updated: May 22, 2022
Page reviewed: May 22, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.